111 related articles for article (PubMed ID: 25710585)
1. BRAFV600E Gene Mutation in Colonic Adenocarcinomas. Immunohistochemical Detection Using Tissue Microarray and Clinicopathologic Characteristics: An 86 Case Series.
Boulagnon C; Dudez O; Beaudoux O; Dalstein V; Kianmanesh R; Bouché O; Diebold MD
Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):88-96. PubMed ID: 25710585
[TBL] [Abstract][Full Text] [Related]
2. The utility of BRAFV600E mutation-specific antibody for colon cancers with microsatellite instability.
Nolan S; Arnason T; Drucker A; Huang WY
Appl Immunohistochem Mol Morphol; 2014; 22(5):e8-e13. PubMed ID: 24805134
[TBL] [Abstract][Full Text] [Related]
3. [Comparative analysis of real-time quantitative PCR-Sanger sequencing method and TaqMan probe method for detection of KRAS/BRAF mutation in colorectal carcinomas].
Zhang X; Wang Y; Gao N; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Feb; 43(2):77-82. PubMed ID: 24742565
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal cancers in Taiwan is highly concordant with the molecular test.
Hang JF; Li AF; Chang SC; Liang WY
Histopathology; 2016 Jul; 69(1):54-62. PubMed ID: 26588428
[TBL] [Abstract][Full Text] [Related]
5. A modified Lynch syndrome screening algorithm in colon cancer: BRAF immunohistochemistry is efficacious and cost beneficial.
Roth RM; Hampel H; Arnold CA; Yearsley MM; Marsh WL; Frankel WL
Am J Clin Pathol; 2015 Mar; 143(3):336-43. PubMed ID: 25696791
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.
Kuan SF; Navina S; Cressman KL; Pai RK
Hum Pathol; 2014 Mar; 45(3):464-72. PubMed ID: 24529329
[TBL] [Abstract][Full Text] [Related]
7. BRAF V600E-specific immunohistochemistry for the exclusion of Lynch syndrome in MSI-H colorectal cancer.
Capper D; Voigt A; Bozukova G; Ahadova A; Kickingereder P; von Deimling A; von Knebel Doeberitz M; Kloor M
Int J Cancer; 2013 Oct; 133(7):1624-30. PubMed ID: 23553055
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of the BRAF V600E mutant protein in colorectal neoplasms.
Vakiani E; Yaeger R; Brooke S; Zhou Y; Klimstra DS; Shia J
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):438-43. PubMed ID: 25517872
[TBL] [Abstract][Full Text] [Related]
9. BRAF V600E Expression by Immunohistochemistry in Colon Cancer and Clinico-pathologic Features Associated with BRAF-Mutated Colonic Cancers in Mexican Patients.
González-Colunga KJ; Lino-Silva LS; Salcedo-Hernández RA; Ruiz-García EB; Zepeda-Najar C
J Gastrointest Cancer; 2020 Mar; 51(1):35-40. PubMed ID: 30618001
[TBL] [Abstract][Full Text] [Related]
10. BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer.
Ilie MI; Long-Mira E; Hofman V; Mouroux J; Vignaud JM; Gauchotte G; Begueret H; Merlio JP; Emile JF; Hébuterne X; Hofman P
Pathology; 2014 Jun; 46(4):311-5. PubMed ID: 24798160
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.
Zlobec I; Bihl MP; Schwarb H; Terracciano L; Lugli A
Int J Cancer; 2010 Jul; 127(2):367-80. PubMed ID: 19908233
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemistry using the BRAF V600E mutation-specific monoclonal antibody VE1 is not a useful surrogate for genotyping in colorectal adenocarcinoma.
Adackapara CA; Sholl LM; Barletta JA; Hornick JL
Histopathology; 2013 Aug; 63(2):187-93. PubMed ID: 23763264
[TBL] [Abstract][Full Text] [Related]
13. BRAF
Grillo F; Paudice M; Pigozzi S; Dono M; Lastraioli S; Lugaresi M; Bozzano S; Tognoni C; Ali M; Sciallero S; Puccini A; Fassan M; Mastracci L
Histopathology; 2024 Apr; 84(5):877-887. PubMed ID: 38173291
[TBL] [Abstract][Full Text] [Related]
14. Loss of INI1 expression in colorectal carcinoma is associated with high tumor grade, poor survival, BRAFV600E mutation, and mismatch repair deficiency.
Wang J; Andrici J; Sioson L; Clarkson A; Sheen A; Farzin M; Toon CW; Turchini J; Gill AJ
Hum Pathol; 2016 Sep; 55():83-90. PubMed ID: 27184481
[TBL] [Abstract][Full Text] [Related]
15. VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.
Sajanti S; Sirniö P; Väyrynen JP; Tuomisto A; Klintrup K; Mäkelä J; Ristimäki A; Mäkinen MJ
Virchows Arch; 2014 Jun; 464(6):637-43. PubMed ID: 24722974
[TBL] [Abstract][Full Text] [Related]
16. Mutation-specific antibody detects mutant BRAFV600E protein expression in human colon carcinomas.
Sinicrope FA; Smyrk TC; Tougeron D; Thibodeau SN; Singh S; Muranyi A; Shanmugam K; Grogan TM; Alberts SR; Shi Q
Cancer; 2013 Aug; 119(15):2765-70. PubMed ID: 23657789
[TBL] [Abstract][Full Text] [Related]
17. Sporadic microsatellite instability-high colon cancers rarely display immunohistochemical evidence of Wnt signaling activation.
Panarelli NC; Vaughn CP; Samowitz WS; Yantiss RK
Am J Surg Pathol; 2015 Mar; 39(3):313-7. PubMed ID: 25602793
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of BRAF V600E Mutations in High-Level Microsatellite Instability(MSI-H)Colon Cancer - Comparison Between Genetic Testing and Immunohistochemical Staining].
Sakimoto T; Chika N; Suzuki O; Ishibashi K; Tachikawa T; Akagi K; Eguchi H; Okazaki Y; Ishida H
Gan To Kagaku Ryoho; 2016 Nov; 43(12):1693-1695. PubMed ID: 28133101
[TBL] [Abstract][Full Text] [Related]
19. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
Landau MS; Kuan SF; Chiosea S; Pai RK
Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
[TBL] [Abstract][Full Text] [Related]
20. Automated PCR detection of BRAF mutations in colorectal adenocarcinoma: a diagnostic test accuracy study.
Colling R; Wang LM; Soilleux E
J Clin Pathol; 2016 May; 69(5):398-402. PubMed ID: 26537294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
